Alcanza Clinical Research Recognized for Advancing Community-Based Clinical Trials
How can healthcare organizations ensure that clinical research truly reflects the communities it serves? The Healthcare Private Equity Association (HCPEA) has recognized Alcanza Clinical Research (Alcanza) with its 2025 HCPEA Impact Award, honoring the organization’s mission-driven approach to advancing inclusive, community-based clinical research nationwide.
Alcanza, a leading network of fully owned, community-based clinical research sites, has been recognized for its significant impact on healthcare. The HCPEA Impact Award honors one healthcare organization each year that exemplifies the vital role private equity plays in strengthening the healthcare system. As stated by Carlos Orantes, CEO of Alcanza, “Receiving the HCPEA Impact Award is an incredible honor and a reflection of the passion our teams bring to expanding access to clinical research every day.
Key Insights at a Glance
- Impact Award: Alcanza Clinical Research received the 2025 HCPEA Impact Award for its mission-driven approach.
- Community-Based Research: Alcanza operates a network of 25 clinical research sites nationwide.
- Inclusive Research: The organization focuses on expanding participation among historically underrepresented populations.
- Growth and Diversity: Alcanza has grown the number of active studies more than fourfold and achieved high participant diversity.
Breaking Down Barriers in Clinical Research
Just as a bridge connects two distant shores, Alcanza Clinical Research connects communities to vital clinical trials. The core challenge in the healthcare industry is ensuring that clinical research is inclusive and reflective of diverse populations. Historically, clinical trials have faced significant barriers, including logistical, educational, and trust-based issues. Alcanza addresses these challenges by meeting patients where they are, through purpose-built facilities and a focus on research quality and rapid study startup. This approach is crucial for advancing medical progress and ensuring that treatments are effective for all communities.
The Urgency of Inclusive Research
The window for action is closing fast. As healthcare disparities continue to widen, the need for inclusive clinical research has never been more urgent. Alcanza’s ability to expand participation among historically underrepresented populations is a critical step in addressing these disparities. Mario Moreno, Partner at Martis Capital and Alcanza Board Member, emphasizes, “Alcanza embodies exactly what the HCPEA Impact Award was created to recognize. The organization demonstrates how thoughtful investment, strong leadership, and a clear mission can drive meaningful improvements in health equity, research quality, and innovation.”
Alcanza Clinical Research Mobilizes for Inclusive Trials
Alcanza Clinical Research is committed to expanding access to clinical research and ensuring that medical progress reflects the communities it serves. Alcanza Clinical Research has significantly scaled its impact over the past few years, growing the number of active studies more than fourfold and achieving participant diversity levels that remain uncommon across the industry. With more than 25 clinical research sites nationwide, Alcanza Clinical Research continues to break down barriers that have traditionally limited participation in clinical trials. The organization’s mission is to conduct multi-phase trials efficiently while expanding participation among historically underrepresented populations, reinforcing its commitment to inclusive, compassionate research that delivers life-changing outcomes.
Future Outlook
Alcanza Clinical Research is like a lighthouse guiding the way forward in the complex landscape of clinical research. By focusing on community-based, inclusive trials, the organization is setting a new standard for the industry. As Alcanza continues to grow and expand its impact, the future holds the promise of more diverse and effective medical treatments. The organization’s stated goal is to continue breaking down barriers and ensuring that clinical research truly reflects the communities it aims to serve.
Conclusion
The recognition of Alcanza Clinical Research with the 2025 HCPEA Impact Award underscores the organization’s significant contributions to advancing inclusive, community-based clinical research. By expanding access and ensuring diversity, Alcanza is playing a crucial role in strengthening the healthcare system and delivering life-changing outcomes. Join the conversation in the comments below.
About HCPEA
The Healthcare Private Equity Association (HCPEA) is a nonprofit trade association whose mission is to support the reputation, knowledge, and relationships of the healthcare private equity community. Its member firms are passionate about healthcare and are committed to building successful enduring businesses that “do well” while “doing good.” As well as capital, HCPEA members bring industry knowledge, broad networks, and deep expertise to help companies grow, create jobs, and deliver high-quality healthcare.
Source link: https://www.businesswire.com/
